Thermo Fisher director receives stock award

Thermo Fisher Scientific director Scott M. Sperling received an award of 499 shares of Common Stock at no cost, classified as a grant or other acquisition.

Rhea-AI Filing Summary

Thermo Fisher Scientific director Scott M. Sperling received an award of 499 shares of Common Stock at no cost, classified as a grant or other acquisition. After this compensation grant, he directly holds 69,479 shares of Thermo Fisher Scientific common stock.

Insider Trade Summary

Grant/Award: 499 shares

Grant/Award 1 txn

Insider SPERLING SCOTT M

Role Director

Type	Security	Shares	Price	Value
Grant/Award	Common Stock	499	$0.00	$0.00

Holdings After Transaction: Common Stock — 69,479 shares (Direct)

Key Figures

Shares granted: 499 shares Grant price: $0.00 per share Shares held after grant: 69,479 shares

3 metrics

Shares granted 499 shares Common Stock grant, transaction code A

Grant price $0.00 per share Compensation-related equity award

Shares held after grant 69,479 shares Direct holdings following transaction

Key Terms

Grant, award, or other acquisition, non-derivative, Common Stock

3 terms

Grant, award, or other acquisition financial

"Transaction code description: Grant, award, or other acquisition"

non-derivative financial

"The transaction involves non-derivative Common Stock"

Common Stock financial

"Security title for the transaction is Common Stock"

Common stock represents ownership shares in a company, giving investors a stake in its success and a say in important decisions through voting rights. It is the most common type of stock traded on markets and can provide income through dividends, as well as potential for value growth. For investors, holding common stock means sharing in the company’s profits and risks.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What did Thermo Fisher (TMO) director Scott M. Sperling report on this Form 4?

Scott M. Sperling reported receiving 499 shares of Thermo Fisher Scientific Common Stock as a grant or award. The shares were acquired at no cost and represent compensation, increasing his direct holdings to 69,479 shares after the transaction.

How many Thermo Fisher (TMO) shares does Scott M. Sperling hold after this grant?

After the reported grant, Scott M. Sperling directly holds 69,479 shares of Thermo Fisher Scientific Common Stock. This total reflects his position immediately following the acquisition of 499 new shares classified as a grant or other award-type acquisition.

Was the Thermo Fisher (TMO) Form 4 transaction a market purchase or sale?

The transaction was not a market purchase or sale. It is coded as a grant, award, or other acquisition of 499 shares of Common Stock at a price of $0.00 per share, indicating a compensation-related share award rather than an open-market trade.

What transaction code is used in Scott M. Sperling’s Thermo Fisher (TMO) Form 4?

The Form 4 uses transaction code A, described as a grant, award, or other acquisition. This code indicates the 499 shares of Common Stock were received as a non-derivative equity award, rather than purchased or sold in the open market.

Is Scott M. Sperling’s ownership in Thermo Fisher (TMO) direct or indirect after this Form 4?

Scott M. Sperling’s reported ownership is direct after this transaction. The filing classifies his nature of ownership as direct, with 69,479 shares of Common Stock held directly following the 499-share grant or award acquisition.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 05/22/2026 - 04:16 PM EDT Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

SPERLING SCOTT M

(Last) (First) (Middle)

C/O THOMAS H. LEE PARTNERS, L.P.

100 FEDERAL STREET, 36TH FLOOR

(Street)

BOSTON MASSACHUSETTS 02110

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
THERMO FISHER SCIENTIFIC INC. [ TMO ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
05/20/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	05/20/2026		A		499	A	$0	69,479	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

	/s/ Melodie T. Morin, Attorney-in-Fact for Scott M. Sperling	05/22/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)